Cerebrospinal fluid glutamate inversely correlates with positive symptom severity in unmedicated male schizophrenic/schizoaffective patients

This publication has 38 references indexed in Scilit:

• Glutamate in schizophrenia: clinical and research implications
  Schizophrenia Research, 1997
• Ketamine-Induced Exacerbation of Psychotic Symptoms and Cognitive Impairment in Neuroleptic-Free Schizophrenics
  Neuropsychopharmacology, 1997
• Immunoautoradiographic evidence for a loss of α-amino-3-hydroxy-5-methyl-4-isoxazole propionate-preferring non-N-methyl-D-aspartate glutamate receptors within the medial temporal lobe in schizophrenia
  Biological Psychiatry, 1997
• Double-Blind, Placebo-Controlled, Crossover Trial of Glycine Adjuvant Therapy for Treatment-Resistant Schizophrenia
  The British Journal of Psychiatry, 1996
• NMDA Receptor Function and Human Cognition: The Effects of Ketamine in Healthy Volunteers
  Neuropsychopharmacology, 1996
• Effects of haloperidol on CSF glutamate levels in drug-naive schizophrenic patients
  Schizophrenia Research, 1995
• Limbic/mesolimbic connections and the pathogenesis of schizophrenia
  Biological Psychiatry, 1991
• Decreased hippocampal expression of a glutamate receptor gene in schizophrenia
  The Lancet, 1991
• Chronic Haloperidol Administration Enhances the γ-Aminobutyric Acid Level in the Rat Striatum without Altering the Glutamate Level
  European Neurology, 1984
• STUDIES OF THE INTER‐RELATIONSHIP BETWEEN CEREBROSPINAL FLUID AND PLASMA AMINO ACID CONCENTRATIONS IN NORMAL INDIVIDUALS
  Journal of Neurochemistry, 1977